HCA Holdings (HCA) Tops Q4 EPS by 55c, Offers FY21 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
HCA Healthcare Reports Fourth Quarter 2020 Results and Provides 2021 Guidance
February 2, 2021 7:30 AM ESTCompany Reinstates and Increases Quarterly Dividend; Resumes Share Repurchase Program and Increases Authorization
NASHVILLE, Tenn.--(BUSINESS WIRE)-- HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2020.
Key fourth quarter metrics (all percentage changes compare 4Q 2020 to 4Q 2019 unless otherwise noted):
Revenues totaled $14.293 billion Net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share Adjusted EBITDA totaled $3.118 billion Cash flows used in operating activities totaled $3.583... More